Knowledge about Cervical Cancer and Pap Smear and the Factors Influencing the Pap test Screening among Women
- PMID: 28409172
- PMCID: PMC5385241
Knowledge about Cervical Cancer and Pap Smear and the Factors Influencing the Pap test Screening among Women
Abstract
Background: Although the Pap smear is known as one of the effective methods to detect the cervical cancer, a large group of women are reluctant to do the test because of various reasons. Therefore, we carried out this study to determine the level of knowledge about cervical cancer and Pap smear and the factors influencing the Pap test screening among women.
Methods: In this cross-sectional study, 355 women referred to the health centers of Gilan-e gharb city were randomly recruited in 2015. The participants asked to complete a self-administered questionnaire including five parts (questions about: demographic factors, knowledge about cervical cancer and Pap smear, Pap smear performance, barriers and facilitators related to Pap smear and the sources of information). Data were analyzed through SPSS version 19, using descriptive statistics, Independent T-test, and logistic regression.
Results: The mean age of the participants was 34.08±7.81 years. Almost 50.4% of the subjects had a history of Pap smear test. Pap test performance was significantly higher in those who had higher knowledge (P<0.001). Knowledge about cervical cancer, Pap smear and age was the most important predictors of the Pap test performance (P<0.001). The most important barrier and facilitator to Pap smear test were inadequate knowledge and the recommendations received from family, friends and healthcare professionals (44.3% and 40.2%, respectively).
Conclusion: Knowledge about Pap smear and cervical cancer was important in predicting Pap test doing. In addition, inadequate knowledge was introduced as the most important barrier to screening test from the perspective of women. Therefore, we suggest that health education and health promotion studies as interdisciplinary and targeted interventions should be implemented to improve the women's knowledge.
Keywords: Barriers; Cervical cancer; Facilitators; Pap smear; Knowledge.
Similar articles
-
Evaluation of cervical cancer screening program at a rural community of South Africa.East Afr J Public Health. 2008 Aug;5(2):111-6. East Afr J Public Health. 2008. PMID: 19024420
-
Young Singaporean women's knowledge of cervical cancer and pap smear screening: a descriptive study.J Clin Nurs. 2013 Dec;22(23-24):3310-9. doi: 10.1111/jocn.12420. J Clin Nurs. 2013. PMID: 24580785
-
Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women.Asian Pac J Cancer Prev. 2016;17(S3):263-8. doi: 10.7314/apjcp.2016.17.s3.263. Asian Pac J Cancer Prev. 2016. PMID: 27165236
-
Awareness and uptake of the Pap smear among market women in Lagos, Nigeria.J Public Health Afr. 2011 Feb 14;2(1):e14. doi: 10.4081/jphia.2011.e14. eCollection 2011 Mar 1. J Public Health Afr. 2011. PMID: 28299055 Free PMC article. Review.
-
Inadequate clinical data on Pap test request form: Where are we headed in the era of precision medicine?Cytojournal. 2020 Jan 31;17:1. doi: 10.25259/Cytojournal_87_2019. eCollection 2020. Cytojournal. 2020. PMID: 32256667 Free PMC article. Review.
Cited by
-
Effectiveness of a culturally tailored text messaging program for promoting cervical cancer screening in accra, Ghana: a quasi-experimental trial.BMC Womens Health. 2024 Jan 3;24(1):22. doi: 10.1186/s12905-023-02867-2. BMC Womens Health. 2024. PMID: 38172883 Free PMC article. Clinical Trial.
-
Knowledge, Attitudes and Practices of Women in the Southern Region of Saudi Arabia Regarding Cervical Cancer and the Pap Smear Test.Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1177-1184. doi: 10.31557/APJCP.2019.20.4.1177. Asian Pac J Cancer Prev. 2019. PMID: 31030492 Free PMC article.
-
Prevalence and factors associated with uptake of cervical cancer screening at primary care facilities in Trinidad: a cross-sectional study.BMJ Public Health. 2025 Jun 24;3(1):e001297. doi: 10.1136/bmjph-2024-001297. eCollection 2025. BMJ Public Health. 2025. PMID: 40575068 Free PMC article.
-
miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.Oncol Res. 2018 Jul 5;26(6):923-931. doi: 10.3727/096504017X15143731031009. Epub 2018 Jan 2. Oncol Res. 2018. PMID: 29295729 Free PMC article.
-
Prevalence and Predictors of Cervical Cancer Screening among Reproductive Age Group Women: Evidence from Cross-Sectional Study in Rohtak and Delhi.Asian Pac J Cancer Prev. 2022 Aug 1;23(8):2771-2777. doi: 10.31557/APJCP.2022.23.8.2771. Asian Pac J Cancer Prev. 2022. PMID: 36037133 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917. - PubMed
-
- Jemal A, Center MM, DeSantis C, Ward EM. Global Patterns of Cancer Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893–907. - PubMed
-
- Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine. 2005;23:2388–94. - PubMed
-
- Saraiya M, Ahmed F, Krishnan S, et al. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109:360–70. - PubMed
-
- Wright TC Jr, Cox JT, Massed LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials